are glp 1 drugs dangerous Long-Term Effects Of GLP-1 Medications: What You Should Know Diabetes patients who stop GLP-1

Description

Kastin AJ, Akerstrom V

M.SatoT.ZhangL

Abstract Recent large clinical trials on sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists, with the aim of verifying cardiovascular safety, have revealed that these medications have a preventative advantage on adverse cardiovascular outcomes, including worsening of heart failure and deterioration of nephropathy, in patients with type 2 diabetes (T2D)

Possible mechanisms for their beneficial effects in individuals with NAFLD are: (i) reduction of visceral adipose tissue and thus IR

Financial Reasons (Most Common): No Insurance Coverage The Problem: Insurance doesnt cover Mounjaro for weight loss Plan only covers diabetes medications Need type 2 diabetes diagnosis for coverage The Solution: Compounded tirzepatide at $349/month saves $720/month ($8,640/year) while providing the same active ingredient